Our Team

Frank Taffy is a life sciences executive, entrepreneur, board member and strategic advisor with over twenty years of experience, primarily in the areas of corporate development and business operations.

Frank currently serves as Chief Business Officer of Congruence Therapeutics.  He was Senior Vice President and Head of Business Development for Schrödinger, Inc., a New York-based company leveraging an integrated digital chemistry platform for drug discovery. He additionally serves as Board Member of Faxian Therapeutics (a joint venture with WuXi AppTec), Helocyte and Cellvation. Frank co-founded Helocyte and Cellvation, both clinical-stage biopharmaceutical companies, and previously served as their President and Chief Executive Officer.

He previously served as Head of Business Affairs at Forest Laboratories (now AbbVie, Inc.), where he led the optimization and expansion of the company’s portfolio of marketed pharmaceutical products. Prior to joining Forest, Frank served as Director of Corporate Development at Life Technologies, Inc. (now Thermo Fisher Scientific), where he led partnering and investment activities, and held board positions on behalf of the company. Frank previously also served as Vice President and General Counsel for a global healthcare investment firm where he directed the formation and interim operation of multiple portfolio companies.

He started his career as an intellectual property transactional attorney at the Procter and Gamble Company. Frank received a bachelor’s degree in biochemistry from the University of North Texas and a Juris Doctor degree from Syracuse University College of Law.